Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2020-05-15 2020-05-15
Drug Identification Number 02483548 02483548
Brand name BELSOMRA BELSOMRA
Common or Proper name suvorexant tablets suvorexant tablets
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients SUVOREXANT SUVOREXANT
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30TAB 30TAB
ATC code N05CM N05CM
ATC description
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-05-14 2020-05-14
Remaining supply date 2020-05-14 2020-05-14
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments